| Name: | Etoricoxib Related Compound B |
| Catalogue No. | VL1020003 |
| CAS No. | 90536-66-6 |
| Molecular Formula | C₉H₁₀O₄S |
| Molecular Weight | 214.24 |
| Status | In-stock |
| IUPAC Name | [p-(Methylsulfonyl)phenyl]-acetic Acid |
| Synonyms | Etoricoxib EP Impurity B |
| Description | Etoricoxib Related Compound B (CAS No: 90536-66-6) or [p-(Methylsulfonyl)phenyl]-acetic Acid, it is a selective inhibitor of cyclo-oxygenase 2 (COX-2), which is used in the treatment of patients suffering from chronic arthropathies and musculoskeletal and dental pain. |
| References | Sci-Hub | Clinical Pharmacokinetic and Pharmacodynamic Profile of Etoricoxib. Clinical Pharmacokinetics, 47(11), 703–720 | 10.2165/00003088-200847110-00002. (2022). Sci-Hub.se. https://sci-hub.se/https://doi.org/10.2165/00003088-200847110-00002 |
![1-(6-Methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]-ethanone Oxime](/public/site/files/site_images/thumb_16methyl3pyridinyl24methylsulfonylphenylethanone-oxime53878.png)
